|
MCCC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.70663483345379E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.94450044744121E-11 |
| Normal-vs-Stage2 |
1.64296999999314E-05 |
| Normal-vs-Stage3 |
2.07060000034787E-07 |
| Normal-vs-Stage4 |
1.68897999999196E-05 |
| Stage1-vs-Stage2 |
7.712000E-01 |
| Stage1-vs-Stage3 |
9.183800E-01 |
| Stage1-vs-Stage4 |
5.439600E-01 |
| Stage2-vs-Stage3 |
7.434400E-01 |
| Stage2-vs-Stage4 |
4.438800E-01 |
| Stage3-vs-Stage4 |
5.969000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.85662596408065E-12 |
| Normal-vs-AfricanAmerican |
2.42660003202388E-09 |
| Normal-vs-Asian |
2.680500E-03 |
| Caucasian-vs-AfricanAmerican |
8.251000E-01 |
| Caucasian-vs-Asian |
9.858800E-01 |
| AfricanAmerican-vs-Asian |
9.548200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.66044955562938E-12 |
| Normal-vs-Female |
9.45440004063158E-09 |
| Male-vs-Female |
4.509200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.53340004530145E-09 |
| Normal-vs-Extreme_Weight |
1.62536650805123E-12 |
| Normal-vs-Obese |
6.53299969677335E-10 |
| Normal-vs-Extreme_Obese |
8.275200E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.385600E-01 |
| Normal_Weight-vs-Obese |
4.065400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.949000E-01 |
| Extreme_Weight-vs-Obese |
7.241900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.978410E-01 |
| Obese-vs-Extreme_Obese |
3.188400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.38009999983701E-07 |
| Normal-vs-Age(41-60Yrs) |
1.63613567139009E-12 |
| Normal-vs-Age(61-80Yrs) |
4.33609814720626E-11 |
| Normal-vs-Age(81-100Yrs) |
6.36840000000083E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.478800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.745400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.429000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.995000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.443600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.696800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.6242562850266E-12 |
| Normal-VS-Type2 PRCC |
4.20990000000732E-05 |
| Normal-VS-KIRP CIMP |
2.59240000022309E-07 |
| Normal-VS-Unclassified PRCC |
6.93739999890752E-08 |
| Type1 PRCC-VS-Type2 PRCC |
3.834000E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.213620E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.349420E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.114100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.445210E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.552500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.3754999623502E-09 |
| Normal-vs-N1 |
1.1103999997264E-07 |
| Normal-vs-N2 |
1.396950E-03 |
| N0-vs-N1 |
6.892200E-01 |
| N0-vs-N2 |
5.324400E-01 |
| N1-vs-N2 |
6.512000E-01 |
|
|
